Drug Trial Radar · NCT01547741
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Last checked: Nov 19, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,242
Actual
Start
Apr 2012
Primary completion
May 31, 2022
Study completion Oct 17, 2025
Sponsor
- Lead sponsor
- NSABP Foundation IncResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Mar 8, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of breast cancer cells, either by killing the cells or by stopping them from dividing. Giving the drugs in different combinations may kill more breast cancer cells. Giving combination chemotherapy after surgery may kill any tumor cells that remain after surgery. PURPOSE: This randomized phase III trial is studying different combination chemotherapy regimens and their side effects and comparing how well they work in treating women with non-metastatic breast cancer.
Conditions
- Breast Cancer
Interventions
DoxorubicinDrug
CyclophosphamideDrug
DocetaxelDrug
PaclitaxelDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Invasive Disease-free Survival (IDFS)Time frame: Assessed before each cycle of chemotherapy, 3-4 weeks after completion of chemotherapy, every 6 months through 5 years and yearly years 6-10.
Locations
915 sites in 2 countries. Site status is shown where the registry gives one.
Providence Alaska Medical Center
Anchorage, Alaska
Arizona Oncology Associates-Biltmore Cancer Center
Phoenix, Arizona
Premiere Oncology of Arizona
Scottsdale, Arizona
Sedona Medical Center
Sedona, Arizona
Arizona Oncology Associates
Tucson, Arizona
NEA Baptist Clinic-Matthews
Jonesboro, Arkansas
Kaiser Anaheim Medical Center
Anaheim, California
Kaiser Permanente-Deer Valley Medical Center
Antioch, California
Kaiser Permanente Medical Group - Baldwin Park
Baldwin Park, California
Kaiser Foundation Hospital
Bellflower, California
Providence Saint Joseph Medical Center
Burbank, California
East Bay Radiation Oncology Center
Castro Valley, California
Valley Medical Oncology Consultants-Castro Valley
Castro Valley, California
Epic Care-Dublin
Dublin, California
Northbay Cancer Center
Fairfield, California
Kaiser Permanente Hospital
Fontana, California
Kaiser Permanente, Fremont
Fremont, California
Valley Medical Oncology Consultants-Fremont
Fremont, California
Washington Hospital
Fremont, California
California Cancer Center - North Fresno
Fresno, California
Kaiser Permanente
Fresno, California
Kaiser Permanente - Harbor City
Harbor City, California
Kaiser Permanente, Hayward
Hayward, California
Southern California Permanente Medical Group
Irvine, California
UC San Diego Moores Cancer Center
La Jolla, California
Long Beach Memorial Medical Center-Todd Cancer Institute
Long Beach, California
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California
Kaiser Permanente
Los Angeles, California
Kaiser Permanente-West Los Angeles
Los Angeles, California
Cedars-Sinai Medical Center
Los Angeles, California
Contra Costa Regional Medical Center
Martinez, California
Memorial Medical Center
Modesto, California
Kaiser Permanente-Modesto
Modesto, California
Community Hospital of Monterey Peninsula
Monterey, California
El Camino Hospital
Mountain View, California
Highland General Hospital
Oakland, California
Alta Bates Summit Medical Center - Summit Campus
Oakland, California
Bay Area Breast Surgeons Inc
Oakland, California
Bay Area Tumor Institute
Oakland, California
Larry G Strieff MD Medical Corporation
Oakland, California
Showing 40 of 915 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.